{"id":"https://genegraph.clinicalgenome.org/r/2d73bd4a-c42b-4fa3-907f-b0ec922b3b15v1.0","type":"EvidenceStrengthAssertion","dc:description":"","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/2d73bd4a-c42b-4fa3-907f-b0ec922b3b15","GCISnapshot":"https://genegraph.clinicalgenome.org/r/dcea255c-11e4-46fd-b0f7-2de68311a75c","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/dcea255c-11e4-46fd-b0f7-2de68311a75c_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10010","date":"2020-09-01T00:00:00Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/dcea255c-11e4-46fd-b0f7-2de68311a75c_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10010","date":"2018-01-23T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/aaf208a3-de99-4210-b8b3-a38b928c676b_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10010","date":"2020-09-01T00:00:00Z","role":"Unpublisher"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dcea255c-11e4-46fd-b0f7-2de68311a75c_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/56de28da-428a-47d6-b9d7-01dd72cbd853_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/08eae841-f206-46ca-b546-3dfe50d4242d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16146704","rdfs:label":"Patient 3","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":23,"detectionMethod":"Total RNA was isolated from cultured skin fibroblasts of patients 1 and 3 and used to prepare cDNA. The CPT1A cDNA was amplified in three overlapping segments and sequenced as previously described.","phenotypeFreeText":"Blood glucose was 0.4 mmol/L. A semi-quantitative test for ketones was negative in plasma and urine.","phenotypes":["obo:HP_0001298","obo:HP_0002181","obo:HP_0001943"],"previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/56de28da-428a-47d6-b9d7-01dd72cbd853_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16146704","allele":{"id":"https://genegraph.clinicalgenome.org/r/552f4bda-a978-4467-8e42-74fab1c3a51b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001876.3(CPT1A):c.1600delC (p.Leu534Terfs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/65648"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/aa966ad7-54a1-48e6-803f-d604f1dffaee_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f735f85d-4cc1-4f1d-8b0c-1e8dd5a34748","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12189492","rdfs:label":"Patient 4","ageType":"AgeAtOnset","ageUnit":"Days","ageValue":3,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0001985","obo:HP_0001943","obo:HP_0002240","obo:HP_0001635"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/aa966ad7-54a1-48e6-803f-d604f1dffaee_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12189492","allele":[{"id":"https://genegraph.clinicalgenome.org/r/53b30e8e-eb92-4dd7-9fca-0496626879d4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001876.3(CPT1A):c.1876-1G>A (p.Val626_Glu676del)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/9067"}},{"id":"https://genegraph.clinicalgenome.org/r/6cf4fcf7-eae6-467a-96fd-a7ce6c09e8ad","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NG_011801.1:g.72149_72150delTT","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/9064"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/6b06ecb3-0f25-4e52-a355-ed49280c4da8_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cb24009a-e886-406e-85b7-27955e8d9b39","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16146704","rdfs:label":"Patient 1","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":14,"detectionMethod":"Total RNA was isolated from cultured skin fibroblasts of patients 1 and 3 and used to prepare cDNA. The CPT1A cDNA was amplified in three overlapping segments and sequenced as previously described.","phenotypeFreeText":"Plasma was lipemic with glucose 4.4 mmol/L, ammonia 34 μmol/L (20–60), AST 466 U (2–60), ALT 398 U (6–53), CPK 1948 U (0–170), myoglobin 22.4 ng/ml (0–5).","phenotypes":["obo:HP_0000388","obo:HP_0001254","obo:HP_0001298"],"previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/6b06ecb3-0f25-4e52-a355-ed49280c4da8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16146704","allele":{"id":"https://genegraph.clinicalgenome.org/r/96064a95-4e3b-4876-aa6c-9cc2e5e6a22a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001876.3(CPT1A):c.1737C>A (p.Tyr579Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/65649"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/c5ff8a11-ea81-41d0-aba3-f45b34aaf065_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f20a3c07-2a30-4830-a1c3-e251ab2fb23b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16146704","rdfs:label":"Patient 2","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":3,"detectionMethod":"Genomic DNA was extracted from a blood spot as described previously. Subsequently, exon 4 of the CPT1A gene was amplified by PCR using the intronic primers and analyzed by sequencing.","ethnicity":{"id":"cg:NotHispanicOrLatino"},"phenotypeFreeText":"Initial blood glucose was 0.6 mmol/L. A semi-quantitative test for ketones in urine was negative. Plasma AST was 503 U (2–60), ALT 341 U (6–53), CPK 260 U (0–170).","phenotypes":["obo:HP_0002240","obo:HP_0001943","obo:HP_0001298"],"previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/c5ff8a11-ea81-41d0-aba3-f45b34aaf065_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16146704","allele":{"id":"https://genegraph.clinicalgenome.org/r/da038ae5-161c-4d6f-a2f5-d44d509da11b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001876.3(CPT1A):c.478C>T (p.Arg160Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/65654"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/e0cc6f44-c75b-4f2b-8fa0-b5fa31ebbbc6_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1d635c6f-f1eb-463f-9583-63e4f5ecbe37","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12189492","rdfs:label":"Patient 3","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":14,"detectionMethod":"","firstTestingMethod":"PCR","phenotypes":["obo:HP_0008341","obo:HP_0001414","obo:HP_0001259","obo:HP_0001942","obo:HP_0000105","obo:HP_0002240","obo:HP_0001254"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/e0cc6f44-c75b-4f2b-8fa0-b5fa31ebbbc6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12189492","allele":{"id":"https://genegraph.clinicalgenome.org/r/c7525436-a300-4589-90b1-4ef4f989ed7c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001876.3(CPT1A):c.(?_1744)_2107del (p.(?))","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/9068"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/46689d98-9bf0-46ef-98cc-1408728eb811_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ab68746b-88f8-4424-96d3-f2dd301ecc9f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12189492","rdfs:label":"Patient 1","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":8,"detectionMethod":"All exons and intron-exon boundaries were sequenced.","firstTestingMethod":"PCR","phenotypes":["obo:HP_0002240","obo:HP_0001250","obo:HP_0001259"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/46689d98-9bf0-46ef-98cc-1408728eb811_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12189492","allele":{"id":"https://genegraph.clinicalgenome.org/r/731e8d3f-0d75-4cd0-9bee-ed5ed5062fb9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001876.3(CPT1A):c.298C>T (p.Gln100Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/9063"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/a95bcbaf-5081-4b98-b96f-66533abb7f4e_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/acd33b73-f6e2-4553-a29d-1b4e8dc17882","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9691089","rdfs:label":"S.I.","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":15,"detectionMethod":"Sequenced the coding region for CPT1A  using cDNA from fibroblasts of control subjects and index patient.","firstTestingMethod":"PCR","phenotypeFreeText":"Mild dicarboxylic aciduria is not a common feature of CPTI deficiency but has been reported before.","phenotypes":["obo:HP_0001985","obo:HP_0002240","obo:HP_0011968","obo:HP_0002014","obo:HP_0001252","obo:HP_0003215","obo:HP_0001254"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/a95bcbaf-5081-4b98-b96f-66533abb7f4e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9691089","allele":{"id":"https://genegraph.clinicalgenome.org/r/f743fdd1-4628-43ca-bb20-77e06bd40c38","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001876.3(CPT1A):c.1361A>G (p.Asp454Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/9061"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/540e220b-aa71-4269-a3fc-dc1520dbd51c_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b8f70e56-b8cc-4ee9-a4a2-a1bbacef6a49","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12189492","rdfs:label":"Patient 2","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":14,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0001250","obo:HP_0001942","obo:HP_0001259","obo:HP_0001254","obo:HP_0001433","obo:HP_0001943","obo:HP_0000967"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/540e220b-aa71-4269-a3fc-dc1520dbd51c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12189492","allele":[{"id":"https://genegraph.clinicalgenome.org/r/d2cde34c-9578-47dc-8ef9-1e3a2fcf585c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001876.3(CPT1A):c.1241C>T (p.Ala414Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/9065"}},{"id":"https://genegraph.clinicalgenome.org/r/637dd329-a2bc-440d-9555-4456269e0cb1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001876.3(CPT1A):c.1493A>G (p.Tyr498Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/9066"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/dcea255c-11e4-46fd-b0f7-2de68311a75c_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dcea255c-11e4-46fd-b0f7-2de68311a75c_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/46dc56f4-c6d3-42a7-9480-fa6789ddfb55","type":"EvidenceLine","dc:description":"Mice recapitulated some aspects of the disease.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7aef9f42-424e-4931-8dd3-ad2b952021f0","type":"Finding","dc:description":"Homozygous CPT1a deficiency was embryonic lethal in the mouse mutant. In heterozygotes, there was a decrease in CPT-1 activity in the liver compared to wild type (only in males). Serum glucose concentrations after a 24h fast were lower in male hets and serum-free fatty acids were elevated compared to controls. Both male and female hets were found to be cold intolerant.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16169268","rdfs:label":"Nyman 2005 Mouse Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/dcea255c-11e4-46fd-b0f7-2de68311a75c_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/34ca2c0f-fbd7-4af9-8da9-7c3d885dce4c","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f7bc5171-ba03-4fa9-aa9d-0e3ec8376396","type":"FunctionalAlteration","dc:description":"CPT1 deficiency resulted in an inhibition of LCFA oxidation and KB production. CPT reaction is a rate limiting step of the LCFA pathway. KB production was restored to normal when given MCT since the medium-chain fatty acids are converted to their derivatives in the mitochondria, so the CPT reaction is bypassed.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7014807","rdfs:label":"Bougneres 1981 FA"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/dcea255c-11e4-46fd-b0f7-2de68311a75c_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/72d17b3f-6e0d-4c0e-8c91-b75ad79cf0fd","type":"EvidenceLine","dc:description":"Well-established disease mechanism.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4d4f077b-7332-43f2-afb6-9f7800065a75","type":"Finding","dc:description":"OMIM: \"The CPT1A gene encodes carnitine palmitoyltransferase IA, a liver enzyme involved in fatty acid oxidation. The carnitine palmitoyltransferase (CPT; EC 2.3.1.21) enzyme system, in conjunction with acyl-CoA synthetase and carnitine/acylcarnitine translocase (613698), provides the mechanism whereby long-chain fatty acids are transferred from the cytosol to the mitochondrial matrix to undergo beta-oxidation for energy production.\"","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15363638","rdfs:label":"Bonnefont 2004 Function","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/bb51d487-dba3-42f6-8c29-2f7008aed6d3","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6e61c097-5771-4e88-915a-c5e2ae97cce8","type":"Finding","dc:description":"Northern blot analysis of total RNA from human liver.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7892212","rdfs:label":"Britton 1995 Expression","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":3.5}],"evidenceStrength":"Definitive","sequence":640,"specifiedBy":"GeneValidityCriteria6","strengthScore":15.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/JK9tPDplqy8","type":"GeneValidityProposition","disease":"obo:MONDO_0009705","gene":"hgnc:2328","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_aaf208a3-de99-4210-b8b3-a38b928c676b-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}